GeneSight® Pharmacogenomic Testing
GeneSight is a clinically validated pharmacogenomic test designed to analyze how your genes may impact the metabolism and effectiveness of common psychiatric medications—including antidepressants, anti-anxiety agents, ADHD treatments, and mood stabilizers. Administered via a simple cheek-swab, testing can be completed in-office or at home. Results are typically available for your provider within 1–2 business days
Book an Appointment
About service:
Insurance Coverage & Cost Transparency
Insurance Type: Expected Patient Cost Medicare (Part B) Typically $0 out of pocket Medicaid Typically $0 out of pocket Medicare Advantage/CommercialMost patients pay ≤ $330 out of pocket Uninsured / Out‑of‑NetworkReduced flat self-pay rate (~$330)
GeneSight Promise: Over 98% of tested patients pay $330 or less; if projected costs exceed this cap, GeneSight will contact you for confirmation before processing.
Financial Assistance: Interest-free payment plans are available for balances of $100+; additional programs may help eligible patients under income-based federal poverty guidelines.
Billing Process: GeneSight bills your insurer directly. You’ll receive an Explanation of Benefits in 30–45 days, followed by any remaining patient responsibility. Billing is paused for review before the cap is confirmed.
How Psychvisit Supports You
Order Coordination – Arrange testing, whether in-office or at-home.
Benefit Counseling – Explain any costs, payment plans, and assistance programs available.
Clinical Integration – We interpret results in context of your treatment history, side effect profile, and current medications to guide personalized care decisions.